Long Covid: study shows damage to brain's 'control centre'
Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
Damage to the brain's "control centre" might be behind the long-term breathlessness, fatigue and anxiety experienced by long Covid sufferers.
Researchers from the universities of Cambridge and Oxford used ultra-high-resolution scanners to study the brains of 30 people who had been admitted to hospital with severe Covid-19 early in the pandemic, before vaccines were available.
The results, published in the journal Brain, may help scientists and clinicians understand the long-term effects of Covid-19 on the brain and the rest of the body. They could also improve treatments for other conditions such as MS and dementia.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What did the study find?
Powerful MRI scanners, known as 7-Tesla or 7T, were able to study in fine detail the brains of those suffering from Covid, and compare them with the scans of 51 people with no history of infection.
Researchers found signs of inflammation in the brainstem, a "small but critical structure that governs life-sustaining bodily functions such as breathing, heart rate and blood pressure", said The Guardian.
What does it mean?
The scans suggest that severe Covid infections can provoke an "immune reaction" that inflames the brainstem, "with the resulting damage producing symptoms that can last for months after patients have been discharged".
The fact that these "abnormalities" were in the parts of the brain associated with breathing "strongly suggests that long-lasting symptoms are an effect of inflammation in the brainstem following Covid-19 infection", said Dr Catarina Rua, a neuroscientist at the University of Cambridge and first author on the study.
The condition known as long Covid or post-Covid syndrome (PCS) can cause extreme tiredness, shortness of breath, brain fog, dizziness, heart palpitations and muscle aches lasting for 12 weeks or more, according to the Nice guidelines.
Those with the highest levels of brainstem inflammation were also found to have the highest levels of depression and anxiety – another key symptom of long Covid – "because of the tight connection between physical and mental health", said Professor James Rowe, also from Cambridge, who co-led the research.
Does it change how Covid should be treated?
There is still a lot to be learned about long Covid. This study doesn't "conclusively prove" the causes, but it does "point a finger at one possible suspect for some of the symptoms experienced", said Paul Mullins, a professor in neuroimaging at the University of Bangor. The results suggest it might be useful to "reduce inflammatory responses during initial Covid infection and response".
The researchers said the study might also be useful in understanding other conditions such as MS and dementia that are associated with brainstem inflammation.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
5 inflammatory cartoons on the L.A. wildfires
Cartoons Artists take on climate change denial, the blame game, and more
By The Week US Published
-
The problems with the current social care system
The Explainer The question of how to pay for adult social care is perhaps the greatest unresolved policy issue of our time
By The Week UK Published
-
Austria's new government: poised to join Putin's gang
Talking Point Opening for far-right Freedom Party would be a step towards 'the Putinisation of central Europe'
By The Week UK Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Polycystic ovary syndrome: what it is, how it's treated and why it's often misunderstood
The Explainer PCOS affects millions, but there is still no cure outside of treating symptoms separately
By Theara Coleman, The Week US Published
-
The growing list of conditions weight-loss drugs could help with
The Explainer Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
By Theara Coleman, The Week US Published
-
ADHD drugs shortage: what's behind it?
The Explainer Supply chain issues and 'tripling' of prescriptions concerns GPs as problems getting medication become 'desperate'
By The Week UK Published
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
By The Week UK Published